[ad_1] The Swiss pharmaceutical company Roche has announced the launch of ocrelizumab, the first monoclonal antibody that slows the progression of multiple sclerosis in early and advanced stages, stopping the attack of …
Read More »
[ad_1] In Mexico, treatments for patients with multiple sclerosis cost between 20,000 and 600,000 pesos a year. Photo: AP COLOMBIA Patients with multiple sclerosis in advanced stages advanced in Mexico will have …
Read More »
[ad_1] Cali – Improve the early diagnosis of these diseases and other diseases such as bad cancer, hemophilia A (defective blood clotting) and multiple sclerosis (chronic disease of the nervous system) is …
Read More »
[ad_1] Researchers from the University of the Basque Country (Northern Spain) found a molecular key to delay the progression of multiple sclerosis, a finding published in EMBO Molecular Medicine journal scientist ] …
Read More »